Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.6800 (-3.52%) ($6.9200 - $7.9000) on Mon. Aug. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.46% (three month average) | RSI | 76 | Latest Price | $7.6800(-3.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -4.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 26.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BND(48%) BWX(16%) TLT(15%) CEMB(13%) SIL(12%) | Factors Impacting CAPR price | CAPR will decline at least -4.23% in a week (0% probabilities). XOP(-22%) EDOC(-22%) XLI(-20%) XLF(-20%) XLB(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.23% (StdDev 8.46%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
5 Day Moving Average | $8.4(-8.57%) | 10 Day Moving Average | $7.86(-2.29%) | 20 Day Moving Average | $6.37(20.57%) | To recent high | -21.7% | To recent low | 53.3% | Market Cap | $151m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |